Cardiac dysfunction

There are 291 papers on cardiac dysfunction in aging research: 1 trial and 35 observational studies in people, 210 in animals, 2 in cells, 40 reviews. The newest story, Nov 7, 2026: “Gut microbes from old mice impaired young mice’s hearts”.

Disease

291 papers study it365 more mention it42 findings

59 new papers in 30 daysSee all 656 papers on cardiac dysfunction

“we validated comorbidity of CD and AD/D based on diagnostic records from millions of patients in Korea and the University of California, San Francisco Medical Center”
Identification of a pleiotropic effect of ADIPOQ on cardiac dysfunction and Alzheimer's disease based on genetic evidence and health care recordsTranslational psychiatry2022doi:10.1038/s41398-022-02144-0
  • Human trial1
  • Humans35
  • Animals199
  • Model organisms11
  • Cells2
  • In silico1

Interventions

20

Endurance exercise

downin flies1downin mice1

2 studies
  1. Endurance exercise decreases cardiac dysfunction in aging Drosophila.

    “Endurance exercise training alleviated obesity-related cardiac dysfunction and locomotor impairment by upregulating muscle Gγ1 expression in aging Drosophila”

    Model organismsin aging Drosophilamuscle

    Endurance exercise improves age- and obesity-related cardiac dysfunction and locomotor impairment through muscle Gγ1 gene in Drosophila

    Life sciences

  2. Endurance exercise decreases cardiac dysfunction in HFD/HF-fed mice.

    “EXE ameliorated HFD/HF-induced body weight gain and hyperglycemia, improved insulin signaling and glucose transporter 4 (GLUT4) levels, and counteracted cardiac disruption.”

    Animalsin HFD/HF-fed miceheart12 wkfemalesn = 11

    Exercise-Induced Antisenescence and Autophagy Restoration Mitigate Metabolic Disorder-Induced Cardiac Disruption in Mice

    Medicine and science in sports and exercise

More on Endurance exercise

Resistance training

no changein humans1

1 study
  1. Resistance training showed no clear effect on cardiac dysfunction in humans (cancer patients treated with anthracyclines; reviewed studies incorporated AR-T).

    “no evidence indicating that resistance training exacerbates cardiac dysfunction.”

    Reviewcancer patients treated with anthracyclines; reviewed studies incorporated AR-T

    Evaluating the safety and cardiac impact of resistance training in anthracycline-treated patients: a systematic review

    Cardio-oncology (London, England)

More on Resistance training

Intermedin1-53

downin mice1

1 study
  1. Intermedin1-53 decreases cardiac dysfunction in mice (aged mice with Ang II infusion or AAC surgery).

    “IMD1−53 alleviated AACR and cardiac dysfunction aggravated by Ang II or pressure-overload”

    Animalsaged mice with Ang II infusion or AAC surgery5 ng/kg/min2 or 4 weeks

    Intermedin₁₋₅₃ improves aging-associated cardiac remodeling and dysfunction via mitochondrial SIRT3-mediated SOD2 deacetylation

    Journal of molecular and cellular cardiology

More on Intermedin1-53

Voluntary wheel running

downin mice1

1 study
  1. Voluntary wheel running protects against cardiac dysfunction in mice (C26 tumor-bearing mice).

    “SED+T also showed 15% reduced grip strength and cardiac dysfunction, while WR+T preserved function.”

    AnimalsC26 tumor-bearing miceheart4 weeksmales

    Concurrent Physical Activity Protects Against C26 Adenocarcinoma Tumor-Mediated Cardiac and Skeletal Muscle Dysfunction and Wasting in Males

    Cells

More on Voluntary wheel running

Gk-nav

downin mice1

1 study
  1. Gk-nav decreases cardiac dysfunction in mice (high-fat diet-induced progeroid mice).

    “leading to a significant improvement in age-related metabolic disorders in adipose tissue and cardiac dysfunction”

    Animalshigh-fat diet-induced progeroid miceself-assembled K36-Gpnmb fusion nanovaccineheart

    Nanovaccine loaded with seno-antigen target senescent cells to improve metabolic disorders of adipose tissue and cardiac dysfunction

    Human vaccines & immunotherapeutics

More on Gk-nav

Nicotinamide mononucleotide

downin mice1

1 study
  1. Nicotinamide mononucleotide protects against cardiac dysfunction in mice (tail suspension model).

    “Oral administration of nicotinamide mononucleotide (NMN, a NAD + precursor) showed similar therapeutic effect to ADSCs treatment”

    Animalstail suspension modelheart

    Mesenchymal stem cells arouse myocardial NAD+ metabolism to alleviate microgravity-induced cardiac dysfunction

    Biochemical and biophysical research communications

More on Nicotinamide mononucleotide

Adipose-derived mesenchymal stem cells

downin mice1

1 study
  1. Adipose-derived mesenchymal stem cells protect against cardiac dysfunction in mice (tail suspension model).

    “emerged preventive and therapeutic effect against myocardial senescence and the decline in cardiac function”

    Animalstail suspension modelheart

    Mesenchymal stem cells arouse myocardial NAD+ metabolism to alleviate microgravity-induced cardiac dysfunction

    Biochemical and biophysical research communications

More on Adipose-derived mesenchymal stem cells

T-aucb

downin mice1

1 study
  1. T-aucb decreases cardiac dysfunction in mice (LPS-induced).

    “genetic deletion or pharmacological inhibition of sEH using trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid attenuated LPS-induced cardiac dysfunction in aged female mice”

    AnimalsLPS-inducedheartfemales

    Cardioprotective response and senescence in aged sEH null female mice exposed to LPS

    American journal of physiology. Heart and circulatory physiology

More on T-aucb

Estradiol

downin rats1

1 study
  1. Estradiol prevents cardiac dysfunction in rats (20 weeks post-Ovx).

    “ERT prevents the increase in left ventricle mass after 10 weeks post-Ovx and the ejection fractionreduction after 20 weeks.”

    Animals20 weeks post-Ovx17-β estradiolheart5 μg/kg/day10 weeksfemalesn = 10

    Early Estrogen Replacement Therapy Attenuates Cardiac Dysfunction Caused by Aging and Ovariectomy in Female Wistar Rats

    Frontiers in bioscience (Landmark edition)

More on Estradiol

Lentiviruses expressing SIRT2

downin mice1

1 study
  1. Lentiviruses expressing SIRT2 decreases cardiac dysfunction in mice (age-related cardiac dysfunction).

    “Intra-myocardial injection of lentiviruses expressing SIRT2 ameliorated age-related cardiac dysfunction in mice”

    Animalsage-related cardiac dysfunctionlentivirus expressing SIRT2heart

    SIRT2 counteracts primate cardiac aging via deacetylation of STAT3 that silences CDKN2B

    Nature aging

More on Lentiviruses expressing SIRT2

All 20

Upstream

11

CIRCHIPK3

downin mice1

1 study
  1. CIRCHIPK3 protects against cardiac dysfunction in mice (shown by cardiomyocyte-specific knockout).

    “Its knockout led to cardiac dysfunction, fibrosis, and aging-related phenotypes”

    Animalsshown by cardiomyocyte-specific knockoutheart

    Circular RNA helps protect against heart aging in mice

    ESC Congress 2026 abstract

More on CIRCHIPK3

SIRT3

is required forin mice1

1 study
  1. SIRT3 is required for cardiac dysfunction in mice (required for IMD1−53 protection in aged mice with Ang II infusion; shown by deletion).

    “SIRT3 deletion attenuated the protective effects of IMD1−53 on myocardial hypertrophy, fibrosis, and cardiac dysfunction in aged mice undergoing Ang II infusion”

    Animalsrequired for IMD1−53 protection in aged mice with Ang II infusion; shown by deletion

    Intermedin₁₋₅₃ improves aging-associated cardiac remodeling and dysfunction via mitochondrial SIRT3-mediated SOD2 deacetylation

    Journal of molecular and cellular cardiology

More on SIRT3

TP53INP1

upin mice1

1 study
  1. TP53INP1 increases cardiac dysfunction in mice (shown by cardiac-specific deficiency in miR-30a-5p knockout mice).

    “cardiac-specific TP53INP1 deficiency ameliorates miR-30a-5p knockout-aggravated cardiac dysfunction and heart senescence”

    Animalsshown by cardiac-specific deficiency in miR-30a-5p knockout miceheart

    SUMOylation of TP53INP1 is involved in miR-30a-5p-regulated heart senescence

    Experimental & molecular medicine

More on TP53INP1

STING1

downin mice1

1 study
  1. STING1 protects against cardiac dysfunction in mice (shown by genetic ablation in aged mice).

    “long-term STING inhibition by genetic ablation exacerbated cardiac dysfunction in aged mice”

    Animalsshown by genetic ablation in aged miceheartlong-term

    Deletion of stimulator of interferons genes aggravated cardiac dysfunction in physiological aged mice

    Mechanisms of ageing and development

More on STING1

EPHX2

upin mice1

1 study
  1. EPHX2 increases cardiac dysfunction in mice (shown by genetic deletion, in LPS-treated aged female mice).

    “genetic deletion or pharmacological inhibition of sEH using trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid attenuated LPS-induced cardiac dysfunction in aged female mice”

    Animalsshown by genetic deletion, in LPS-treated aged female miceheartfemales

    Cardioprotective response and senescence in aged sEH null female mice exposed to LPS

    American journal of physiology. Heart and circulatory physiology

More on EPHX2

CDKN1A

upin mice1

1 study
  1. CDKN1A increases cardiac dysfunction in mice.

    “whereas p21 deletion delayed these changes”

    Animalsshown by knockout (p21-/- mice); deletion delayed the age-related rise in plasma phenylalanine and cardiac dysfunctionmales

    Dysregulated Phenylalanine Catabolism Plays a Key Role in the Trajectory of Cardiac Aging

    Circulation

More on CDKN1A

FGFR1

is required forin rats1

1 study
  1. FGFR1 is required for cardiac dysfunction in rats (time-restricted feeding cardioprotection; shown by cardiac-specific knockdown).

    “both liver-specific knockdown (KD) of FGF21 and cardiac-specific FGFR1 KD abrogated the cardioprotective effects of TRF in HU rats”

    Animalstime-restricted feeding cardioprotection; shown by cardiac-specific knockdownheart

    Time-restricted feeding alleviates cardiac dysfunction induced by simulated microgravity via restoring cardiac FGF21 signaling

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

More on FGFR1

TET2

downin mice1

1 study
  1. TET2 protects against cardiac dysfunction in mice (shown by adoptive transfer of Tet2-mutant bone marrow cells into nonirradiated mice).

    “Mice receiving Tet2-deficient bone marrow cells spontaneously developed age-related cardiac dysfunction characterized by greater hypertrophy and fibrosis.”

    Animalsshown by adoptive transfer of Tet2-mutant bone marrow cells into nonirradiated miceheart

    Tet2-mediated clonal hematopoiesis in nonconditioned mice accelerates age-associated cardiac dysfunction

    JCI insight

More on TET2

Klotho

downin mice1

1 study
  1. Klotho decreases cardiac dysfunction in mice (streptozotocin-induced diabetic mice).

    “Diabetes-induced increases in serum creatine kinase-muscle/brain and lactate dehydrogenase levels, cardiac fibrosis, cardiomyocyte apoptosis, and cardiac dysfunction were ameliorated by Klotho.”

    Animalsstreptozotocin-induced diabetic miceheart12 weeks

    Klotho improves diabetic cardiomyopathy by suppressing the NLRP3 inflammasome pathway

    Life sciences

More on Klotho

Ceramide kinase mutants

upin flies1

1 study
  1. ceramide kinase mutants increase cardiac dysfunction in flies with age in ceramide kinase mutants.

    “In particular, mutants develop cardiac dysfunction with age”

    Model organismswith age in ceramide kinase mutants

    Survival response to increased ceramide involves metabolic adaptation through novel regulators of glycolysis and lipolysis

    PLoS genetics

All 11

Associations

10

Combined nutrition and exercise management

downin humans1OR 0.58

1 study
  1. Combined nutrition and exercise management is associated with cardiac dysfunction in humans (Community-dwelling older adults; multivariable-adjusted analysis) (Adjusted OR 0.58, 95% CI 0.45–0.73).

    “CNE was independently associated with lower odds of frailty progression (adjusted OR 0.62, 95% CI 0.51–0.78) and cardiac dysfunction (adjusted OR 0.58, 95% CI 0.45–0.73).”

    HumansCommunity-dwelling older adults; multivariable-adjusted analysisheartSix monthsn = 1,584

    Association of Combined Nutrition and Exercise Management with Frailty Progression, Functional Performance, and Cardiovascular Outcomes in Community-Dwelling Older Adults: A Retrospective Cohort Study

    Frontiers in nutrition

More on Combined nutrition and exercise management

Fecal microbiota transplantation

mixedin mice1

1 study
  1. Fecal microbiota transplantation is associated with cardiac dysfunction in mice (reciprocal FMT between Akap1+/- and Akap1+/+ mice).

    “Reciprocal FMT between Akap1+/- and Akap1+/+ mice significantly modulated gut barrier permeability, inflammatory markers, and cardiac dysfunction”

    Animalsreciprocal FMT between Akap1+/- and Akap1+/+ mice

    Losing one gene copy impaired heart function in mice

    ESC Congress 2026 abstract

More on Fecal microbiota transplantation

Smartwatch-based machine learning model

upin humans1

1 study
  1. smartwatch-based machine learning model predicts cardiac dysfunction in internal validation cohort (AUC 0.93).

    “The AUCs of cardiac dysfunction model were 0.99 in training cohort, 0.93 in internal validation cohort, and 0.95 in external cohort”

    Humansin internal validation cohortn = 49

    Smartwatch-based machine learning for the detection of cardiac dysfunction

    ESC Congress 2026 abstract

SGLT2 inhibitors

downin humans1OR 0.62

1 study
  1. SGLT2 inhibitors are linked with a lower risk of cardiac dysfunction in cancer patients undergoing chemotherapy (OR 0.62 (95% CI 0.56-0.69)).

    “cardiac dysfunction (OR 0.62, 95% CI 0.56-0.69, P < 0.0002)”

    Humansin cancer patients undergoing chemotherapyheart

    SGLT-2 Inhibitors in the Prevention of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis

    AHA Scientific Sessions 2025 abstract

More on SGLT2 inhibitors

Mortality

upin humans1HR 1.52

1 study
  1. Cardiac dysfunction is linked with a higher risk of mortality in humans (vulnerable CLTI with non-ambulatory status) (HR 1.52, p = 0.04).

    “left ventricular ejection fraction < 50% (HR: 1.52, p = 0.04)”

    Humansvulnerable CLTI with non-ambulatory statusn = 443

    Risk Stratification Model on Mortality in Vulnerable Patients with Chronic Limb-Threatening Ischemia

    AHA Scientific Sessions 2025 abstract

KDM-based age acceleration

upin humans1

1 study
  1. Cardiac dysfunction is associated with KDM-based age acceleration in humans (Acute ischemic stroke; latent multimorbidity patterns) (β = 7.89 (95% CI 3.11–12.66)).

    “followed by cardiac dysfunction (β = 7.89, 95% CI: 3.11-12.66).”

    HumansAcute ischemic stroke; latent multimorbidity patternsn = 2,539

    Association of multimorbidity with biological age acceleration in acute ischemic stroke patients: a cross-sectional study

    QJM : monthly journal of the Association of Physicians

More on KDM-based age acceleration

Senescent cell-derived extracellular vesicles

upin reviews1

1 study
  1. Senescent cell-derived extracellular vesicles are associated with cardiac dysfunction.

    “This has been associated with the development of cardiac dysfunction, fibrosis, and vascular calcification, among others.”

    Review

    Extracellular Vesicles and Cardiac Aging

    Advances in experimental medicine and biology

More on Senescent cell-derived extracellular vesicles

Alzheimer's disease and dementia

upin humans1

1 study
  1. Cardiac dysfunction is associated with Alzheimer's disease and dementia in humans (diagnostic records from Korea and UCSF Medical Center) (odds ratio 11.5 (95% CI 8.5–15.5)).

    “we validated comorbidity of CD and AD/D based on diagnostic records from millions of patients in Korea and the University of California, San Francisco Medical Center”

    Humansdiagnostic records from Korea and UCSF Medical Center

    Identification of a pleiotropic effect of ADIPOQ on cardiac dysfunction and Alzheimer's disease based on genetic evidence and health care records

    Translational psychiatry

More on Alzheimer's disease and dementia

Atrial fibrillation

upin humans1OR 2.373

1 study
  1. Cardiac dysfunction is linked with a higher risk of atrial fibrillation in elderly patients with obstructive sleep apnea (OR=2.373, 95%CI=1.298-4.337, p<0.01).

    “cardiac dysfunction (OR=2.373, 95%CI=1.298-4.337, p<0.01) were relevant to AF among participants with OSA”

    Humansin elderly patients with obstructive sleep apnea

    Prevalence and Factors Associated With Atrial Fibrillation in Elderly Patients With Obstructive Sleep Apnea

    Research SquarePreprint

More on Atrial fibrillation

proton leak

upin animals1

1 study
  1. proton leak is associated with cardiac dysfunction (natural aging).

    “we show direct evidence of increased proton leak in the aged heart mitochondria”

    Animalsnatural agingheart

    Reduction of elevated proton leak rejuvenates mitochondria in the aged cardiomyocyte

    eLife

Trial sponsors

Funding

20 grants since 2016

National Heart, Lung, and Blood Institute$11.3MNational Institute on Aging$5.5MNational Institute of General Medical Sciences$828K

Contains public sector information licensed under the Open Government Licence v3.0.

Latest

Dec 2025: 8Jan 2026: 31Feb 2026: 15Mar 2026: 20Apr 2026: 7May 2026: 16Jun 2026: 12Jul 2026: 7Aug 2026: 13Sep 2026: 15Oct 2026: 44Nov 2026: 19207 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Gut microbes from old mice impaired young mice’s hearts

In transplant experiments, microbes from young donors partly reversed heart dysfunction in old mice aged 18–24 months.In transplant experiments, microbes from young donors partly reversed heart dysfunction in old mice aged 18–24 months.

Frontiers in Cardiovascular Medicine

Heart decline was not linked to shorter telomeres in rats

Relative telomere length in white blood cells remained unchanged: 1.000 at 9 months, 0.939 at 16 months and 1.120 at 24 months.Relative telomere length in white blood cells remained unchanged: 1.000 at 9 months, 0.939 at 16 months and 1.120 at 24 months.

ESC Congress 2026 Abstract

Losing one gene copy impaired heart function in mice

Experiments in mice aged 4–6 and 18–24 months found that deleting one copy of a gene also increased intestinal leakage and inflammation.Experiments in mice aged 4–6 and 18–24 months found that deleting one copy of a gene also increased intestinal leakage and inflammation.

Mouse studyMechanisms
ESC Congress 2026 Abstract

Circular RNA helps protect against heart aging in mice

Deleting circHIPK3 impaired heart function in mice; increasing it restored a heart-protective protein and suppressed an aging-associated pathway.Deleting circHIPK3 impaired heart function in mice; increasing it restored a heart-protective protein and suppressed an aging-associated pathway.

Mouse studyMechanisms

See all 656 papers on cardiac dysfunction